| Literature DB >> 25465383 |
Justin Pulford1,2, Peter M Siba3, Ivo Mueller4,5, Manuel W Hetzel6,7,8.
Abstract
BACKGROUND: This paper aims to assess the sensitivity and specificity of exit interviews as a measure of malaria case management practice as compared to direct observation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25465383 PMCID: PMC4259085 DOI: 10.1186/s12913-014-0628-8
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Selected characteristics of the study sample by survey year and overall
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| ||
| Sex | Male | 286 | 51.8 | 337 | 50.8 | 233 | 53.8 | 856 | 51.9 |
| Female | 266 | 48.2 | 327 | 49.2 | 200 | 46.2 | 793 | 48.1 | |
| Age | 0 - 4 yrs | 249 | 45.0 | 343 | 51.3 | 210 | 48.5 | 802 | 48.5 |
| 5 – 14 yrs | 129 | 23.3 | 124 | 18.6 | 96 | 22.2 | 349 | 21.1 | |
| 15+ yrs | 175 | 31.7 | 201 | 30.1 | 127 | 29.3 | 503 | 30.4 | |
| Region | Southern | 152 | 27.5 | 151 | 22.6 | 151 | 34.9 | 454 | 27.5 |
| Highlands | 141 | 25.5 | 136 | 20.4 | 83 | 19.2 | 360 | 21.8 | |
| Momase | 146 | 26.4 | 198 | 29.6 | 127 | 29.3 | 471 | 28.5 | |
| Islands | 114 | 20.6 | 183 | 27.4 | 72 | 16.6 | 369 | 22.3 | |
Sensitivity and specificity of exit interviews compared to direct observation
|
|
|
|
|
|
|---|---|---|---|---|
|
|
|
|
| |
| Advice: | ||||
| Dosage regimen | 1229 | 1027 | 96.4 (93.6, 98.0) | 53.5 (40.2, 66.2) |
| Dietary | 1251 | 81 | 54.4 (41.9, 66.2) | 94.1 (92.0, 95.6) |
| Adverse effects | 1253 | 36 | 36.2 (16.8, 61.2) | 98.6 (97.6, 99.2) |
| Re-engagement | 1643 | 318 | 57.9 (49.4, 65.9) | 75.2 (70.3, 79.5) |
| Malaria prevention | 1644 | 185 | 69.2 (60.5, 76.7) | 96.9 (95.6, 97.7) |
| Action: | ||||
| RDT/BS completed3 | 1556 | 445 | 94.0 (88.8, 96.8) | 98.1 (95.5, 99.1) |
| Prescription made | 1645 | 1409 | 91.7 (87.8, 94.4) | 97.9 (92.7, 99.4) |
| SP prescribed4 | 1266 | 909 | 83.9 (79.0, 87.7) | 70.6 (63.4, 83.3) |
| 1st dose ingested | 1068 | 548 | 95.5 (93.0, 97.1) | 95.0 (92.4, 96.8) |
| Take away dose | 1067 | 737 | 98.3 (97.1, 98.9) | 88.2 (81.7, 92.6) |
1Observations = the number of participants included in the analysis (i.e. the number of observations carried out); 2Occurrences = the number of times the specified advice/action was observed to have occurred (e.g. in 1027/1229 observed clinical case management cases the participant was provided dosage regimen advice); 3RDT = rapid diagnostic test, BS = bloodslide; 4SP = sulphadoxine-pyrimethamine, SP was the most frequently prescribed antimalarial across the three survey samples and is used here as a measure of how accurately patients/caregivers can recall specific antimalarial medications.
Factors associated with accurate recall of treatment advice
|
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| |
| Interviewee | ||||||||||
| Patient | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
| Caregiver | 1.1 (0.4, 3.0) | 0.78 | 0.3 (0.1, 0.9) | 0.03 | 0.1 (<0.1, 1.0) | 0.05 | 0.9 (0.4, 1.9) | 0.82 | 2.4 (0.9, 6.4) | 0.07 |
| Patient sex | ||||||||||
| Male | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
| Female | 0.7 (0.4, 1.2) | 0.24 | 1.5 (0.6, 4.1) | 0.39 | 0.1 (<0.1, 0.9) | 0.04 | 0.8 (0.5, 1.2) | 0.26 | 0.9 (0.5, 1.7) | 0.83 |
| Patient age | ||||||||||
| < 5 yrs | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
| 5 yrs + | 1.1 (0.6, 2.0) | 0.86 | 1.0 (0.4, 2.5) | 0.99 | 2.6 (0.3, 19.5) | 0.33 | 1.0 (0.5, 1.8) | 0.97 | 1.8 (0.8, 4.3) | 0.17 |
| Consult time | ||||||||||
| <17 mins | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
| 17 mins + | 1.2 (0.6, 2.1) | 0.63 | 0.7 (0.2, 2.1) | 0.51 | 0.1 (<0.1, 0.8) | 0.04 | 1.5 (0.8, 2.8) | 0.19 | 0.6 (0.3, 1.4) | 0.26 |
Factors associated with accurate recall of treatment actions
|
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| |
| Interviewee | ||||||||||
| Patient | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
| Caregiver | 2.9 (1.0, 8.3) | 0.05 | 1.3 (0.8, 2.2) | 0.30 | 1.1 (0.7, 1.8) | 0.71 | 2.0 (0.6, 6.6) | 0.23 | 0.7 (0.1, 3.8) | 0.72 |
| Patient sex | ||||||||||
| Male | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
| Female | 1.5 (0.5, 4.4) | 0.43 | 0.6 (0.5, 0.9) | 0.01 | 1.1 (0.8, 1.7) | 0.50 | 2.6 (1.0, 7.0) | 0.06 | 2.2 (0.7, 7.1) | 0.20 |
| Patient age | ||||||||||
| < 5 yrs | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
| 5 yrs + | 1.7 (0.8, 3.9) | 0.19 | 1.7 (1.0, 2.8) | 0.06 | 1.1 (0.6, 1.7) | 0.84 | 1.0 (0.3, 3.6) | 0.96 | 1.3 (0.3, 6.1) | 0.77 |
| Consult time | ||||||||||
| <17 mins | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
| 17 mins + | 1.3 (0.6, 3.2) | 0.52 | 1.3 (0.8, 2.0) | 0.32 | 1.0 (0.7, 1.6) | 0.83 | 1.1 (0.4, 2.6) | 0.90 | 0.8 (0.3, 2.4) | 0.66 |
1AM = antimalarial; 2SP = sulphadoxine-pyrimethamine.